Investasi
Fitur
BiayaKeamanan
Akademi
Lainnya
Pluang+

Bandingkan Harga & Kinerja Pool Advista Indonesia Tbk. (POOL) vs Organon Pharma Indonesia Tbk. (SCPI)

Pool Advista Indonesia Tbk.Trading
Organon Pharma Indonesia Tbk.Trading

Kinerja harga (24 Jam Terakhir)

Statistik utama

Perbedaan Pool Advista Indonesia Tbk. dan Organon Pharma Indonesia Tbk.: Pool Advista Indonesia Tbk. diperdagangkan di Rp50 (kapitalisasi pasar 117,07 M), sedangkan Organon Pharma Indonesia Tbk. diperdagangkan di Rp29.000 (kapitalisasi pasar 104,4 M). Perbedaan utamanya: Pool Advista Indonesia Tbk. dan Organon Pharma Indonesia Tbk. berukuran mirip dari sisi kapitalisasi pasar. Mana yang lebih baik tergantung tujuan investasimu.

POOLSCPI
Kapitalisasi Pasar
117,07 M104,4 M

Perbandingan imbal hasil

Imbal hasil berjalan pada periode standar

Berita terkini

Berita terbaru kedua aset

POOL
Lihat detail
SCPI
Lihat detail

Tentang Pool Advista Indonesia Tbk.

PT Pool Advista Indonesia Tbk (formerly PT. Pool Asuransi Indonesia Tbk) was established on August 16, 1958 based on the notarial deed of Meester Liem Hie Thaij No.86, the changes of notarial of Anwar Mahajudin. The notarial deed was approved by the Ministry of Justice in his decision letter No.J.A5/104/10 dated December 1, 1958 and was published on State Gazette No. 55, Supplement No. 332 dated July 11, 1961. The Company has branches in Medan, Pekanbaru, Bandar Lampung, Bogor, Cirebon, Surabaya and Samarinda.

Selengkapnya di halaman POOL

Tentang Organon Pharma Indonesia Tbk.

PT Merck Sharp Dohme Pharma Tbk was established within the frame work of the Foreign Capital Investment Law No. 1 year 1967 as amended by Law No. 11 year 1970 based on Notarial Deed No. 17 dated 7 March 1972 of Djojo Muljadi, S.H. The company originally incorporated as PT. Essex Indonesia, as a joint venture between Schering Corporation, a worldwide, research-based pharmaceutical enterprise headquartered in the United States, and an Indonesian businessman.

Selengkapnya di halaman SCPI